Sanofi’s Jevtana® (cabazitaxel) Not Obvious over Docetaxel Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019) CAFC Panel: Circuit Judges Lourie, Moore, and Taranto Opinion by Circuit Judge Lourie See Patent Doc’s Post: https://www.patentdocs.org/2019/08/sanofi-aventis-us-llc-v-dr-reddys-laboratories-inc-fed-cir-2019.html https://www.jevtana.com/ Share: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Click to print (Opens in new window) Print Idenix v. Gilead: Split CAFC Panel at Least Agrees – Valid or Not, Either Way it’s Idenix Loss – Claims Too BroadDateFebruary 4, 2023In relation toCase LawInherency & Therapeutic Mechanisms: Reviewing In re Couvaras – (With No-Frills Diagrams)DateJuly 27, 2023In relation toCase LawSmall Molecule Lens for Viewing Amgen v. SanofiDateJune 26, 2023In relation toCase Law
